Touyun Biotech Group (HKSE:01332) Beta: -1.2015 (As of Jul. 05, 2026)


HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
25 GF Score
Price HK$0.16
GF Value HK$0.16
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Beta?

Touyun Biotech Group HKSE:01332 +16.18% 25 Beta is -1.2015 as of Jul. 05, 2026. GuruFocus rates HKSE:01332 with a GF Score™ of 25/100 and a GF Value™ of HK$0.16 (Fairly Valued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-05), Touyun Biotech Group's Beta is -1.2015.


Touyun Biotech Group  (HKSE:01332) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Touyun Biotech Group Beta Related Terms


Touyun Biotech Group Beta Historical Data

* Premium members only.

The historical data trend for Touyun Biotech Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touyun Biotech Group Beta Chart

Touyun Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 0.53 0.47 0.59 0.05

Touyun Biotech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.38 0.59 0.40 0.05

HKSE:01332 vs SW, PKG, IP: Beta Comparison

For the Packaging & Containers subindustry, Touyun Biotech Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group Beta vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Beta distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Beta falls into.


HKSE:01332
25GF Score
Touyun Biotech Group Ltd HKSE:01332
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touyun Biotech Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -1.2015 mean?
Touyun Biotech Group (HKSE:01332) has a Beta of -1.2015 as of Jul. 05, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Touyun Biotech Group and its competitors.
Is Touyun Biotech Group's Beta too high?
Touyun Biotech Group's current Beta is -1.2015. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Beta compare to SW and PKG?
Touyun Biotech Group's Beta of -1.2015 can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Packaging & Containers company?
A good Beta depends on the Packaging & Containers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Touyun Biotech Group and its competitors. Touyun Biotech Group's current Beta is -1.2015. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.16 — trading 1.3% below its estimated fair value. The current Beta is -1.2015. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Beta is -1.2015 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued. The current stock price of HK$0.16 is trading 1.3% below its estimated GF Value™ of HK$0.16. GuruFocus considers Touyun Biotech Group to be Fairly Valued.

Key valuation signals for HKSE:01332:

  • Beta: -1.2015
  • GF Value™: HK$0.16 vs. price of HK$0.16 (1.3% below fair value)
  • GF Score™: 25/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score

Get the complete analysis for HKSE:01332

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.16
GF Value